Aims: Aerobic vaginitis (AV) is a newly defined clinical entity which may interfere with women's reproductive health and have negative effects on pregnancy. This study was to identify the risk factors for AV. Methods: Participants in this case-control study included healthy women and women with AV. All participants completed a standardized questionnaire covering sociodemographic factors, sexual behaviors, personal hygiene habits and health behaviors. Uni- and multivariate logistic regression analyses were used for statistical evaluation. Results: A total of 290 women of reproductive age were enrolled. In the multivariate analysis, unmarried status (odds ratio [OR] 2.606, 95% confidence interval [CI] 1.257-5.402), use of an intrauterine device (OR 4.989, 95% CI 1.922-12.952), long-term use of antibiotics (OR 11.176, 95% CI 1.363-91.666) and frequent vaginal douching (OR 4.689, 95% CI 1.363-16.135) were independent risk factors for AV. On the contrary, consistent condom use (OR 0.546, 95% CI 0.301-0.991) and college-level education or above (OR 0.255, 95% CI 0.131-0.497) were independent protective factors. Conclusion: Measures that may be considered to prevent AV include enhancing education to improve women's knowledge related to reproductive health, especially unmarried women, encouraging them to consistently use condoms as a contraceptive method, to avoid long-term use of antibiotics and to stop frequent vaginal douching.

1.
Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B: Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002;109:34-43.
2.
Tansarli GS, Kostaras EK, Athanasiou S, Falagas ME: Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis 2013;32:977-984.
3.
Fan A, Yue Y, Geng N, Zhang H, Wang Y, Xue F: Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch Gynecol Obstet 2013;287:329-335.
4.
Donders G, De Wet HG, Hooft P, Desmyter J: Lactobacilli in Papanicolaou smears, genital infections, and pregnancy. Am J Perinatol 1993;10:358-361.
5.
Marconi C, Donders GG, Martin LF, Ramos BR, Duarte MT, Parada CM, Tristao AR, Silva MG: Chlamydial infection in a high risk population: association with vaginal flora patterns. Arch Gynecol Obstet 2012;285:1013-1018.
6.
Donders G, Bellen G, Rezeberga D: Aerobic vaginitis in pregnancy. BJOG 2011;118:1163-1170.
7.
Donati L, Di Vico A, Nucci M, Quagliozzi L, Spagnuolo T, Labianca A, Bracaglia M, Ianniello F, Caruso A, Paradisi G: Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet 2010;281:589-600.
8.
MacPhee RA, Miller WL, Gloor GB, McCormick JK, Hammond JA, Burton JP, Reid G: Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol 2013;79:1835-1842.
9.
Jahic M, Mulavdic M, Hadzimehmedovic A, Jahic E: Association between aerobic vaginitis, bacterial vaginosis and squamous intraepithelial lesion of low grade. Med Arch 2013;67:94-96.
10.
Sobel JD: Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994;171:1215-1220.
11.
Peacocke M, Djurkinak E, Thys-Jacobs S: Treatment of desquamative inflammatory vaginitis with vitamin D: a case report. Cutis 2008;81:75-78.
12.
Peacocke M, Djurkinak E, Tsou HC, Thys-Jacobs S: Desquamative inflammatory vaginitis as a manifestation of vitamin D deficiency associated with Crohn disease: case reports and review of the literature. Cutis 2010;86:39-46.
13.
Edwards L, Friedrich EJ: Desquamative vaginitis: lichen planus in disguise. Obstet Gynecol 1988;71:832-836.
14.
Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
15.
Larsen B, Monif GR: Understanding the bacterial flora of the female genital tract. Clin Infect Dis 2001;32:e69-e77.
16.
Boris S, Suarez JE, Vazquez F, Barbes C: Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998;66:1985-1989.
17.
Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW: Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990;3:335-344.
18.
O'Hanlon DE, Lanier BR, Moench TR, Cone RA: Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis 2010;10:120.
19.
Ma L, Lv Z, Su J, Wang J, Yan D, Wei J, Pei S: Consistent condom use increases the colonization of Lactobacillus crispatus in the vagina. PLoS One 2013;8:e70716.
20.
Yan H, Chen W, Wu H, Bi Y, Zhang M, Li S, Braun KL: Multiple sex partner behavior in female undergraduate students in China: a multi-campus survey. BMC Public Health 2009;9:305.
21.
Santhya KG, Acharya R, Jejeebhoy SJ: Condom use before marriage and its correlates: evidence from India. Int Perspect Sex Reprod Health 2011;37:170-180.
22.
Peddie BA, Bishop V, Bailey RR, McGill H: Relationship between contraceptive method and vaginal flora. Aust N Z J Obstet Gynaecol 1984;24:217-218.
23.
Ocak S, Cetin M, Hakverdi S, Dolapcioglu K, Gungoren A, Hakverdi AU: Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium. Saudi Med J 2007;28:727-731.
24.
Jacobson JC, Turok DK, Dermish AI, Nygaard IE, Settles ML: Vaginal microbiome changes with levonorgestrel intrauterine system placement. Contraception 2014;90:130-135.
25.
Lee NC, Rubin GL, Ory HW, Burkman RT: Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1-6.
26.
Sjöberg I, Grahn E, Håkansson S, Holm SE: Influence of phenoxymethylpenicillin on the vaginal ecosystem. Gynecol Obstet Invest 1992;33:42-46.
27.
Onderdonk AB, Delaney ML, Hinkson PL, DuBois AM: Quantitative and qualitative effects of douche preparations on vaginal microflora. Obstet Gynecol 1992;80:333-338.
28.
Pavlova SI, Tao L: In vitro inhibition of commercial douche products against vaginal microflora. Infect Dis Obstet Gynecol 2000;8:99-104.
29.
Marconi C, Donders GG, Bellen G, Brown DR, Parada CM, Silva MG: Sialidase activity in aerobic vaginitis is equal to levels during bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 2013;167:205-209.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.